BioCryst Pharmaceuticals,Inc. (BCRX)

[stockguard]

Know who owns and what you own!
BioCryst Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 37 U.S.-traded ETFs. BCRX has around 23.8M shares in the U.S. ETF market. The largest ETF holder of BCRX is the SPDR S&P Biotech ETF (XBI), with approximately 13.40M shares. Investors may also find of interest that the ETF with the largest allocation to BCRX stock is SPDR S&P Biotech ETF (XBI), with a portfolio weight of 1.07%. On average, U.S. ETFs allocate 0.14% of BCRX to their portfolios.

Additionally, BCRX is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with BCRX as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 50.31%.

ETFs With BioCryst Pharmaceuticals, Inc.

https://www.etf.com/stock/BCRX